Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era
|
摘要
Highly active antiretroviral therapy(HAART) for humanimmunodeficiency virus(HIV) infection has been widely available in industrialized countries since 1996; its widespread use determined a dramatic decline in acquired immunodeficiency syndrome(AIDS)-related mortality, and consequently, a significant decrease of AIDS-defining cancers. However the increased mean age of HIV-infected patients, prolonged exposure to environmental and lifestyle cancer risk factors, and coinfection with oncogenic viruses contributed to the emergence of other malignancies that are considered non-AIDS-defining cancers(NADCs) as a relevant fraction of morbidity and mortality among HIV-infected people twenty years after HAART introduction. The role of immunosuppression in the pathogenesis of NADCs is not well defined, and future researches should investigate the etiology of NADCs. In the last years there is a growing evidence that intensive chemotherapy regimens and radiotherapy could be safely administrated to HIV-positive patients while continuing HAART. This requires a multidisciplinary approach and a close cooperation of oncologists and HIV-physicians in order to best manage compliance of patients to treatment and to face drug-related side effects. Here we review the main epidemiological features, risk factors and clinical behavior of the more common NADCs, such as lung cancer, hepatocellular carcinoma, colorectal cancer and anal cancer, Hodgkin's lymphoma and some cutaneous malignancies, focusing also on the current therapeutic approaches and preventive screening strategies.
Highly active antiretroviral therapy(HAART) for humanimmunodeficiency virus(HIV) infection has been widely available in industrialized countries since 1996; its widespread use determined a dramatic decline in acquired immunodeficiency syndrome(AIDS)-related mortality, and consequently, a significant decrease of AIDS-defining cancers. However the increased mean age of HIV-infected patients, prolonged exposure to environmental and lifestyle cancer risk factors, and coinfection with oncogenic viruses contributed to the emergence of other malignancies that are considered non-AIDS-defining cancers(NADCs) as a relevant fraction of morbidity and mortality among HIV-infected people twenty years after HAART introduction. The role of immunosuppression in the pathogenesis of NADCs is not well defined, and future researches should investigate the etiology of NADCs. In the last years there is a growing evidence that intensive chemotherapy regimens and radiotherapy could be safely administrated to HIV-positive patients while continuing HAART. This requires a multidisciplinary approach and a close cooperation of oncologists and HIV-physicians in order to best manage compliance of patients to treatment and to face drug-related side effects. Here we review the main epidemiological features, risk factors and clinical behavior of the more common NADCs, such as lung cancer, hepatocellular carcinoma, colorectal cancer and anal cancer, Hodgkin's lymphoma and some cutaneous malignancies, focusing also on the current therapeutic approaches and preventive screening strategies.
Highly active antiretroviral therapy(HAART) for humanimmunodeficiency virus(HIV) infection has been widely available in industrialized countries since 1996; its widespread use determined a dramatic decline in acquired immunodeficiency syndrome(AIDS)-related mortality, and consequently, a significant decrease of AIDS-defining cancers. However the increased mean age of HIV-infected patients, prolonged exposure to environmental and lifestyle cancer risk factors, and coinfection with oncogenic viruses contributed to the emergence of other malignancies that are considered non-AIDS-defining cancers(NADCs) as a relevant fraction of morbidity and mortality among HIV-infected people twenty years after HAART introduction. The role of immunosuppression in the pathogenesis of NADCs is not well defined, and future researches should investigate the etiology of NADCs. In the last years there is a growing evidence that intensive chemotherapy regimens and radiotherapy could be safely administrated to HIV-positive patients while continuing HAART. This requires a multidisciplinary approach and a close cooperation of oncologists and HIV-physicians in order to best manage compliance of patients to treatment and to face drug-related side effects. Here we review the main epidemiological features, risk factors and clinical behavior of the more common NADCs, such as lung cancer, hepatocellular carcinoma, colorectal cancer and anal cancer, Hodgkin's lymphoma and some cutaneous malignancies, focusing also on the current therapeutic approaches and preventive screening strategies.
引文
1 Goedert JJ.The epidemiology of acquired immunodeficiency syndrome malignancies.Semin Oncol 2000;27:390-401[PMID:10950365]
2 Goedert JJ,CotéTR,Virgo P,Scoppa SM,Kingma DW,Gail MH,Jaffe ES,Biggar RJ.Spectrum of AIDS-associated malignant disorders.Lancet 1998;351:1833-1839[PMID:9652666]
3 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR Recomm Rep 1992;41:1-19[PMID:1361652]
4 Palella FJ,Baker RK,Moorman AC,Chmiel JS,Wood KC,Brooks JT,Holmberg SD.Mortality in the highly active antiretroviral therapy era:changing causes of death and disease in the HIV outpatient study.J Acquir Immune Defic Syndr 2006;43:27-34[PMID:16878047 DOI:10.1097/01.qai.0000233310.90484.16]
5 Mocroft A,Ledergerber B,Katlama C,Kirk O,Reiss P,d’Arminio Monforte A,Knysz B,Dietrich M,Phillips AN,Lundgren JD.Decline in the AIDS and death rates in the Euro SIDA study:an observational study.Lancet 2003;362:22-29[PMID:12853195DOI:10.1016/S0140-6736(03)13802-0]
6 Spano JP,Costagliola D,Katlama C,Mounier N,Oksenhendler E,Khayat D.AIDS-related malignancies:state of the art and therapeutic challenges.J Clin Oncol 2008;26:4834-4842[PMID:18591544 DOI:10.1200/JCO.2008.16.8252]
7 Grabar S,Abraham B,Mahamat A,Del Giudice P,Rosenthal E,Costagliola D.Differential impact of combination antiretroviral therapy in preventing Kaposi’s sarcoma with and without visceral involvement.J Clin Oncol 2006;24:3408-3414[PMID:16849755DOI:10.1200/JCO.2005.05.4072]
8 Hoffmann C,Wolf E,Fatkenheuer G,Buhk T,Stoehr A,Plettenberg A,Stellbrink HJ,Jaeger H,Siebert U,Horst HA.Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.AIDS 2003;17:1521-1529[PMID:12824790 DOI:10.1097/00002030-200307040-00013]
9 Bourboulia D,Aldam D,Lagos D,Allen E,Williams I,Cornforth D,Copas A,Boshoff C.Short-and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.AIDS 2004;18:485-493[PMID:15090801]
10 Besson C,Goubar A,Gabarre J,Rozenbaum W,Pialoux G,Chatelet FP,Katlama C,Charlotte F,Dupont B,Brousse N,Huerre M,Mikol J,Camparo P,Mokhtari K,Tulliez M,Salmon-Céron D,BouéF,Costagliola D,Rapha?l M.Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.Blood 2001;98:2339-2344[PMID:11588028 DOI:10.1182/blood.V98.8.2339]
11 Diamond C,Taylor TH,Aboumrad T,Anton-Culver H.Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy:incidence,presentation,treatment,and survival.Cancer 2006;106:128 -135[PMID:16329140 DOI:10.1002/cncr.21562]
12 Grogg KL,Miller RF,Dogan A.HIV infection and lymphoma.J Clin Pathol 2007;60:1365-1372[PMID:18042692 DOI:10.1136/jcp.2007.051953]
13 Engels EA,Pfeiffer RM,Goedert JJ,Virgo P,McN eel TS,Scoppa SM,Biggar RJ.Trends in cancer risk among people with AIDS in the United States 1980-2002.AIDS 2006;20:1645-1654[PMID:16868446 DOI:10.1097/01.aids.0000238411.75324.59]
14 Cobucci RN,Lima PH,de Souza PC,Costa VV,Cornetta Mda C,Fernandes JV,Goncalves AK.Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS:a systematic review.J Infect Public Health 2015;8:1-10[PMID:25294086 DOI:10.1016/j.jiph.2014.08.003]
15 Smith CJ,Ryom L,Weber R,Morlat P,Pradier C,Reiss P,Kowalska JD,de Wit S,Law M,el Sadr W,Kirk O,Friis-Moller N,Monforte Ad,Phillips AN,Sabin CA,Lundgren JD.Trends in underlying causes of death in people with HIV from 1999 to 2011(D:A:D):a multicohort collaboration.Lancet 2014;384:241-248[PMID:25042234 DOI:10.1016/S0140-6736(14)60604-8]
16 Grulich AE,Li Y,McD onald A,Correll PK,Law MG,Kaldor JM.Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis.AIDS 2002;16:1155-1161[PMID:12004274 DOI:10.1097/00002030-200205240-00009]
17 Newnham A,Harris J,Evans HS,Evans BG,Moller H.The risk of cancer in HIV-infected people in southeast England:a cohort study.Br J Cancer 2005;92:194-200[PMID:15583689 DOI:10 .1038/sj.bjc.6602273]
18 Bonnet F,Lewden C,May T,Heripret L,Jougla E,Bevilacqua S,Costagliola D,Salmon D,Chêne G,Morlat P.Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.Cancer 2004;101:317 -324[PMID:15241829 DOI:10.1002/cncr.2035]
19 Silverberg MJ,Chao C,Leyden WA,Xu L,Tang B,Horberg MA,Klein D,Quesenberry CP,Towner WJ,Abrams DI.HIV infection and the risk of cancers with and without a known infectious cause.AIDS 2009;23:2337-2345[PMID:19741479 DOI:10.1097/QAD.0b013e3283319184]
20 Dauby N,De Wit S,Delforge M,Necsoi VC,Clumeck N.Characteristics of non-AIDS-defining malignancies in the HAART era:a clinico-epidemiological study.J Int AIDS Soc 2011;14:16[PMID:21443771 DOI:10.1186/1758-2652-14-16]
21 Patel P,Hanson DL,Sullivan PS,Novak RM,Moorman AC,Tong TC,Holmberg SD,Brooks JT.Incidence of types of cancer among HIV-infected persons compared with the general population in the United States,1992-2003.Ann Intern Med 2008;148:728-736[PMID:18490686 DOI:10.7326/0003-4819-148-10-200805200-00005]
22 Calabresi A,Ferraresi A,Festa A,Scarcella C,Donato F,Vassallo F,Limina R,Castelli F,Quiros-Roldan E.Incidence of AIDSdefining cancers and virus-related and non-virus-related non-AIDSdefining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy,1999-2009.HIV Med 2013;14:481-490[PMID:23560682 DOI:10 .1111/hiv.12034]
23 Engels EA,Brock MV,Chen J,Hooker CM,Gillison M,Moore RD.Elevated incidence of lung cancer among HIV-infected individuals.J Clin Oncol 2006;24:1383-1388[PMID:16549832DOI:10.1200/JCO.2005.03.4413]
24 Simard EP,Engels EA.Cancer as a cause of death among people with AIDS in the United States.Clin Infect Dis 2010;51:957-962[PMID:20825305 DOI:10.1086/656416]
25 Grulich AE,van Leeuwen MT,Falster MO,Vajdic CM.Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients:a meta-analysis.Lancet 2007;370:59-67[PMID:17617273 DOI:10.1016/S0140-6736(07)61050-2]
26 Shiels MS,Cole SR,Kirk GD,Poole C.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.J Acquir Immune Defic Syndr 2009;52:611-622[PMID:19770804DOI:10.1097/QAI.0b013e3181b327ca]
27 Mani D,Haigentz M,Aboulafia DM.Lung cancer in HIV Infection.Clin Lung Cancer 2012;13:6-13[PMID:21802373DOI:10.1016/j.cllc.2011.05.005]
28 Burkhalter JE,Springer CM,Chhabra R,Ostroff JS,Rapkin BD.Tobacco use and readiness to quit smoking in low-income HIV-infected persons.Nicotine Tob Res 2005;7:511-522[PMID:16085522 DOI:10.1080/14622200500186064]
29 Centers for Disease Control and Prevention(CDC).Vital signs:current cigarette smoking among adults aged>or=18 years---United States,2009.MMWR Morb Mortal Wkly Rep 2010;59:1135-1140[PMID:20829747]
30 Flanders WD,Lally CA,Zhu BP,Henley SJ,Thun MJ.Lung cancer mortality in relation to age,duration of smoking,and daily cigarette consumption:results from Cancer Prevention Study II.Cancer Res 2003;63:6556-6562[PMID:14559851]
31 Shcherba M,Shuter J,Haigentz M.Current questions in HIVassociated lung cancer.Curr Opin Oncol 2013;25:511-517[PMID:23942294 DOI:10.1097/CCO.0b013e328363dfdb]
32 Sigel K,Wisnivesky J,Gordon K,Dubrow R,Justice A,Brown ST,Goulet J,Butt AA,Crystal S,Rimland D,Rodriguez-Barradas M,Gibert C,Park LS,Crothers K.HIV as an independent risk factor for incident lung cancer.AIDS 2012;26:1017-1025[PMID:22382152 DOI:10.1097/QAD.0b013e328352d1ad]
33 Chaturvedi AK,Pfeiffer RM,Chang L,Goedert JJ,Biggar RJ,Engels EA.Elevated risk of lung cancer among people with AIDS.AIDS 2007;21:207-213[PMID:17197812 DOI:10.1097/QAD.0b013e3280118fca]
34 Rengan R,Mitra N,Liao K,Armstrong K,Vachani A.Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy:a population-based study.Lancet Oncol 2012;13:1203-1209[PMID:23164952 DOI:10 .1016/S1470-2045(12)70466-7]
35 D’Jaen GA,Pantanowitz L,Bower M,Buskin S,Neil N,Greco EM,Cooley TP,Henry D,Stem J,Dezube BJ,Stebbing J,Aboulafia DM.Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy:a multiinstitutional collaboration.Clin Lung Cancer 2010;11:396-404[PMID:21062730 DOI:10.3816/CLC.2010.n.051]
36 Hakimian R,Fang H,Thomas L,Edelman MJ.Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.J Thorac Oncol 2007;2:268-272[PMID:17409796 DOI:10 .1097/01.JTO.0000263707.31202.d7]
37 Powles T,Nelson M,Bower M.HIV-related lung cancer--a growing concern?Int J STD AIDS 2003;14:647-651[PMID:14596765 DOI:10.1258/095646203322387875]
38 Makinson A,Tenon JC,Eymard-Duvernay S,Pujol JL,Allavena C,Cuzin L,Poizot-Martin I,de la Tribonnière X,CabiéA,Pugliese P,Reynes J,Le Moing V.Human immunodeficiency virus infection and non-small cell lung cancer:survival and toxicity of antineoplastic chemotherapy in a cohort study.J Thorac Oncol 2011;6:1022-1029[PMID:21512403 DOI:10.1097/JTO.0b013e318217b6e0]
39 Persad GC,Little RF,Grady C.Including persons with HIV infection in cancer clinical trials.J Clin Oncol 2008;26:1027-1032[PMID:18309938 DOI:10.1200/JCO.2007.14.5532]
40 Bearz A,Vaccher E,Martellotta F,Spina M,Talamini R,Lleshi A,Cacopardo B,Nunnari G,Berretta M,Tirelli U.Lung cancer in HIV positive patients:the GICAT experience.Eur Rev Med Pharmacol Sci 2014;18:500-508[PMID:24610616]
41 Bedimo R,Chen RY,Accortt NA,Raper JL,Linn C,Allison JJ,Dubay J,Saag MS,Hoesley CJ.Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients:1989-2002.Clin Infect Dis 2004;39:1380-1384[PMID:15494916DOI:10.1086/424883]
42 Berretta M,Cappellani A,Di Benedetto F,Lleshi A,Talamini R,Canzonieri V,Zanet E,Bearz A,Nasti G,Lacchin T,Berretta S,Fisichella R,Balestreri L,Torresin A,Izzi I,Ortolani P,Tirelli U.Clinical presentation and outcome of colorectal cancer in HIVpositive patients:a clinical case-control study.Onkologie 2009;32:319 -324[PMID:19521118 DOI:10.1159/000215719]
43 Berretta M,Zanet E,Basile F,Ridolfo AL,Di Benedetto F,Bearz A,Berretta S,Nasti G,Tirelli U.HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population.Onkologie 2010;33:203-204[PMID:20389148 DOI:10.1159/000292126]
44 Bini EJ,Green B,Poles MA.Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects.Gut 2009;58:1129-1134[PMID:19293177 DOI:10 .1136/gut.2008.165985]
45 Franceschi S,Lise M,Clifford GM,Rickenbach M,Levi F,Maspoli M,Bouchardy C,Dehler S,Jundt G,Ess S,Bordoni A,Konzelmann I,Frick H,Dal Maso L,Elzi L,Furrer H,Calmy A,Cavassini M,Ledergerber B,Keiser O.Changing patterns of cancer incidence in the early-and late-HAART periods:the Swiss HIV Cohort Study.Br J Cancer 2010;103:416-422[PMID:20588274DOI:10.1038/sj.bjc.6605756]
46 Gotti D,Raffetti E,Albini L,Sighinolfi L,Maggiolo F,Di Filippo E,Ladisa N,Angarano G,Lapadula G,Pan A,Esposti AD,Fabbiani M,FocàE,Scalzini A,Donato F,Quiros-Roldan E.Survival in HIVinfected patients after a cancer diagnosis in the cA RT Era:results of an italian multicenter study.PLoS One 2014;9:e94768[PMID:24760049 DOI:10.1371/journal.pone.0094768]
47 Guiguet M,BouéF,Cadranel J,Lang JM,Rosenthal E,Costagliola D.Effect of immunodeficiency,HIV viral load,and antiretroviral therapy on the risk of individual malignancies(FHDH-ANRS CO4):a prospective cohort study.Lancet Oncol 2009;10:1152-1159[PMID:19818686 DOI:10.1016/S1470-2045(09)70282-7]
48 Babu CK,Suwansrinon K,Bren GD,Badley AD,Rizza SA.HIV induces TRAIL sensitivity in hepatocytes.PLoS One 2009;4:e4623[PMID:19247452 DOI:10.1371/journal.pone.0004623]
49 Sulkowski MS,Thomas DL,Chaisson RE,Moore RD.Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.JAMA 2000;283:74-80[PMID:10632283 DOI:10.1001/jama.283.1.74]
50 Clifford GM,Rickenbach M,Polesel J,Dal Maso L,Steffen I,Ledergerber B,Rauch A,Probst-Hensch NM,Bouchardy C,Levi F,Franceschi S.Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.AIDS 2008;22:2135-2141[PMID:18832877 DOI:10.1097/QAD.0b013e32831103ad]
51 Berretta M,Garlassi E,Cacopardo B,Cappellani A,Guaraldi G,Cocchi S,De Paoli P,Lleshi A,Izzi I,Torresin A,Di Gangi P,Pietrangelo A,Ferrari M,Bearz A,Berretta S,Nasti G,Di Benedetto F,Balestreri L,Tirelli U,Ventura P.Hepatocellular carcinoma in HIV-infected patients:check early,treat hard.Oncologist 2011;16:1258-1269[PMID:21868692 DOI:10.1634/theoncologist.2010-0400]
52 Bower M,Palfreeman A,Alfa-Wali M,Bunker C,Burns F,Churchill D,Collins S,Cwynarski K,Edwards S,Fields P,Fife K,Gallop-Evans E,Kassam S,Kulasegaram R,Lacey C,Marcus R,Montoto S,Nelson M,Newsom-Davis T,Orkin C,Shaw K,Tenant-Flowers M,Webb A,Westwell S,Williams M.British HIV Association guidelines for HIV-associated malignancies 2014.HIV Med 2014;15 Suppl 2:1-92[PMID:24528810 DOI:10.1111/hiv.12136]
53 Vibert E,Duclos-Vallée JC,Ghigna MR,Hoti E,Salloum C,Guettier C,Castaing D,Samuel D,Adam R.Liver transplantation for hepatocellular carcinoma:the impact of human immunodeficiency virus infection.Hepatology 2011;53:475-482[PMID:21274869DOI:10.1002/hep.24062]
54 Di Benedetto F,Tarantino G,Ercolani G,Baccarani U,Montalti R,De Ruvo N,Berretta M,Adani GL,Zanello M,Tavio M,Cautero N,Tirelli U,Pinna AD,Gerunda GE,Guaraldi G.Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients.Oncologist 2013;18:592-599[PMID:23666950 DOI:10.1634/theoncologist.2012-0255]
55 Rockstroh JK,Bhagani S,Benhamou Y,Bruno R,Mauss S,Peters L,Puoti M,Soriano V,Tural C.European AIDS Clinical Society(EACS)guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.HIV Med 2008;9:82-88[PMID:18257771 DOI:10.1111/j.1468-1293.2007.00535.x]
56 Clausen LN,Lundbo LF,Benfield T.Hepatitis C virus infection in the human immunodeficiency virus infected patient.World J Gastroenterol 2014;20:12132-12143[PMID:25232248 DOI:10 .3748/wjg.v20.i34.12132]
57 Biggar RJ,Jaffe ES,Goedert JJ,Chaturvedi A,Pfeiffer R,Engels EA.Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.Blood 2006;108:3786-3791[PMID:16917006 DOI:10 .1182/blood-2006-05-024109]
58 Engels EA,Biggar RJ,Hall HI,Cross H,Crutchfield A,Finch JL,Grigg R,Hylton T,Pawlish KS,Mc Neel TS,Goedert JJ.Cancer risk in people infected with human immunodeficiency virus in the United States.Int J Cancer 2008;123:187-194[PMID:18435450DOI:10.1002/ijc.23487]
59 Said JW.Immunodeficiency-related Hodgkin lymphoma and its mimics.Adv Anat Pathol 2007;14:189-194[PMID:17452815DOI:10.1097/PAP.0b013e31805048fc]
60 Rezk SA,Weiss LM.Epstein-Barr virus-associated lymphoproliferative disorders.Hum Pathol 2007;38:1293-1304[PMID:17707260 DOI:10.1016/j.humpath.2007.05.020]
61 Spina M,Carbone A,Gloghini A,Serraino D,Berretta M,Tirelli U.Hodgkin’s Disease in Patients with HIV Infection.Adv Hematol 2011;2011:pii:402682[PMID:20936156 DOI:10.1155/2011/402682]
62 Berenguer J,Miralles P,Ribera JM,Rubio R,Valencia E,Mahillo B,Pintado V,Palacios R,Montes ML,Téllez MJ,La Cruz J,TorreCisneros J,Rodríguez-Arrondo F,Sepúlveda MA,Gutiérrez F,Peralta G,Boix V.Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.J Acquir Immune Defic Syndr 2008;47:422 -428[PMID:18434957 DOI:10.1097/QAI.0b013e31815e722b]
63 Levine AM,Li P,Cheung T,Tulpule A,Von Roenn J,Nathwani BN,Ratner L.Chemotherapy consisting of doxorubicin,bleomycin,vinblastine,and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin’s disease:a prospective,multi-institutional AIDS clinical trials group study(ACTG 149).J Acquir Immune Defic Syndr 2000;24:444-450[PMID:11035615 DOI:10.1097/00126334-200008150-00009]
64 Hartmann P,Rehwald U,Salzberger B,Franzen C,Sieber M,W?hrmann A,Diehl V.BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection.Ann Oncol 2003;14:1562-1569[PMID:14504059 DOI:10.1093/annonc/mdg408]
65 Spina M,Gabarre J,Rossi G,Fasan M,Schiantarelli C,Nigra E,Mena M,Antinori A,Ammassari A,Talamini R,Vaccher E,di Gennaro G,Tirelli U.Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.Blood 2002;100:1984-1988[PMID:12200356 DOI:10.1182/blood-2002-03-0989]
66 Spina M,Rossi G,Antinori A.VEBEP regimen and highly active antiretroviral therapy(HAART)in patients(pts)with HD and HIV infection(HD-HIV)-ASCO.J Clin Oncol 2007;25:8083
67 Krishnan A,Molina A,Zaia J,Smith D,Vasquez D,Kogut N,Falk PM,Rosenthal J,Alvarnas J,Forman SJ.Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.Blood 2005;105:874-878[PMID:15388574 DOI:10 .1182/blood-2004-04-1532]
68 Re A,Michieli M,Casari S,Allione B,Cattaneo C,Rupolo M,Spina M,Manuele R,Vaccher E,Mazzucato M,Abbruzzese L,Ferremi P,Carosi G,Tirelli U,Rossi G.High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma:long-term results of the Italian Cooperative Group on AIDS and Tumors(GICAT)study with analysis of prognostic factors.Blood 2009;114:1306-1313[PMID:19451551 DOI:10.1182/blood-2009-02-202762]
69 Zanet E,Berretta M,Martellotta F,Cacopardo B,Fisichella R,Tavio M,Berretta S,Tirelli U.Anal cancer:Focus on HIV-positive patients in the HAART-era.Curr HIV Res 2011;9:70-81[PMID:21410431 DOI:10.2174/157016211795569087]
70 D’Souza G,Wiley DJ,Li X,Chmiel JS,Margolick JB,Cranston RD,Jacobson LP.Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.J Acquir Immune Defic Syndr 2008;48:491-499[PMID:18614927 DOI:10.1097/QAI.0b013e31817aebfe]
71 Piketty C,Selinger-Leneman H,Bouvier AM,Belot A,MaryKrause M,Duvivier C,Bonmarchand M,Abramowitz L,Costagliola D,Grabar S.Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment:results from the french hospital database on HIV.J Clin Oncol 2012;30:4360-4366[PMID:23091098 DOI:10.1200/JCO.2012.44.5486]
72 Kreuter A,Potthoff A,Brockmeyer NH,Gambichler T,Swoboda J,Stücker M,Schmitt M,Pfister H,Wieland U.Anal carcinoma in human immunodeficiency virus-positive men:results of a prospective study from Germany.Br J Dermatol 2010;162:1269-1277[PMID:20184584 DOI:10.1111/j.1365-2133.2010.09712.x]
73 Watson AJ,Smith BB,Whitehead MR,Sykes PH,Frizelle FA.Malignant progression of anal intra-epithelial neoplasia.ANZ J Surg 2006;76:715-717[PMID:16916390 DOI:10.1111/j.1445-2197.2006.03837.x]
74 Frisch M,Biggar RJ,Goedert JJ.Human papillomavirusassociated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.J Natl Cancer Inst 2000;92:1500-1510[PMID:10995805 DOI:10.1093/jnci/92.18.1500]
75 Machalek DA,Poynten M,Jin F,Fairley CK,Farnsworth A,Garland SM,Hillman RJ,Petoumenos K,Roberts J,Tabrizi SN,Templeton DJ,Grulich AE.Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men:a systematic review and meta-analysis.Lancet Oncol 2012;13:487 -500[PMID:22445259 DOI:10.1016/S1470-2045(12)70080-3]
76 Cleator S,Fife K,Nelson M,Gazzard B,Phillips R,Bower M.Treatment of HIV-associated invasive anal cancer with combined chemoradiation.Eur J Cancer 2000;36:754-758[PMID:10762748]
77 Dandapani SV,Eaton M,Thomas CR,Pagnini PG.HIV-positive anal cancer:an update for the clinician.J Gastrointest Oncol 2010;1:34 -44[PMID:22811803 DOI:10.3978/j.issn.2078-6891.2010.005]
78 Lam JM,Hoch JS,Tinmouth J,Sano M,Raboud J,Salit IE.Costeffectiveness of screening for anal precancers in HIV-positive men.AIDS 2011;25:635-642[PMID:21139488 DOI:10.1097/QAD.0b013e3283434594]
79 Kreimer AR,González P,Katki HA,Porras C,Schiffman M,Rodriguez AC,Solomon D,Jiménez S,Schiller JT,Lowy DR,van Doorn LJ,Struijk L,Quint W,Chen S,Wacholder S,Hildesheim A,Herrero R.Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women:a nested analysis within the Costa Rica Vaccine Trial.Lancet Oncol 2011;12:862-870[PMID:21865087 DOI:10.1016/S1470-2045(11)70213-3]
80 Mehrany K,Weenig RH,Lee KK,Pittelkow MR,Otley CC.Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.J Am Acad Dermatol 2005;53:1067-1071[PMID:16310071 DOI:10 .1016/j.jaad.2005.08.055]
81 Euvrard S,Kanitakis J,Claudy A.Skin cancers after organ transplantation.N Engl J Med 2003;348:1681-1691[PMID:12711744 DOI:10.1056/NEJMra022137]
82 Crum-Cianflone N,Hullsiek KH,Satter E,Marconi V,Weintrob A,Ganesan A,Barthel RV,Fraser S,Agan BK.Cutaneous malignancies among HIV-infected persons.Arch Intern Med 2009;169:1130-1138[PMID:19546414 DOI:10.1001/archinternmed.2009.104]
83 Clifford GM,Polesel J,Rickenbach M,Dal Maso L,Keiser O,Kofler A,Rapiti E,Levi F,Jundt G,Fisch T,Bordoni A,De Weck D,Franceschi S.Cancer risk in the Swiss HIV Cohort Study:associations with immunodeficiency,smoking,and highly active antiretroviral therapy.J Natl Cancer Inst 2005;97:425-432[PMID:15770006 DOI:10.1093/jnci/dji072]
84 Olsen CM,Knight LL,Green AC.Risk of melanoma in people with HIV/AIDS in the pre-and post-HAART eras:a systematic review and meta-analysis of cohort studies.PLo S One 2014;9:e95096[PMID:24740329 DOI:10.1371/journal.pone.0095096]
85 Maurer TA,Christian KV,Kerschmann RL,Berzin B,Palefsky JM,Payne D,Tyring SK,Berger TG.Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients.A study of epidemiologic risk factors,human papillomavirus,and p53expression.Arch Dermatol 1997;133:577-583[PMID:9158410DOI:10.1001/archderm.1997.03890410031004]
86 Lobo DV,Chu P,Grekin RC,Berger TG.Nonmelanoma skin cancers and infection with the human immunodeficiency virus.Arch Dermatol 1992;128:623-627[PMID:1575523 DOI:10.1001/archderm.1992.01680150053003]
87 Hausauer AK,Maurer T,Leslie KS,Parvataneni R,Stuart SE,Chren MM.Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus.JAMA Dermatol 2013;149:239-241[PMID:23426494 DOI:10.1001/2013.jamadermatol.245]
88 Izikson L,Nornhold E,Iyer JG,Nghiem P,Zeitouni NC.Merkel cell carcinoma associated with HIV:review of 14patients.AIDS 2011;25:119-121[PMID:21119325 DOI:10.1097/QAD.0b013e328340a19c]
89 Engels EA,Frisch M,Goedert JJ,Biggar RJ,Miller RW.Merkel cell carcinoma and HIV infection.Lancet 2002;359:497-498[PMID:11853800 DOI:10.1016/S0140-6736(02)07668-7]
90 Feng H,Shuda M,Chang Y,Moore PS.Clonal integration of a polyomavirus in human Merkel cell carcinoma.Science 2008;319:1096-1100[PMID:18202256 DOI:10.1126/science.1152586]
91 Foulongne V,Kluger N,Dereure O,Brieu N,Guillot B,Segondy M.Merkel cell polyomavirus and Merkel cell carcinoma,France.Emerg Infect Dis 2008;14:1491-1493[PMID:18760031DOI:10.3201/eid1409.080651]
92 Becker JC,Houben R,Ugurel S,Trefzer U,Pfohler C,Schrama D.MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.J Invest Dermatol 2009;129:248-250[PMID:18633441 DOI:10.1038/jid.2008.198]
93 Brugnaro P,Morelli E,Fiscon M,Ebo F,Rosini G,Belussi F,Eseme F,Mione CA,Donisi PM,Raise E.Sustained remission of a primary nodal Merkel cell carcinoma in an HIV-positive patient.Onkologie 2011;34:190-192[PMID:21447977 DOI:10 .1159/000327000]
94 Busse PM,Clark JR,Muse VV,Liu V.Case records of the Massachusetts General Hospital.Case 19-2008.A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma.N Engl J Med 2008;358:2717-2723[PMID:18565865 DOI:10.1056/NEJMcpc0803063]
95 Paulson KG,Iyer JG,Blom A,Warton EM,Sokil M,Yelistratova L,Schuman L,Nagase K,Bhatia S,Asgari MM,Nghiem P.Systemic immune suppression predicts diminished Merkel cell carcinomaspecific survival independent of stage.J Invest Dermatol 2013;133:642 -646[PMID:23190897 DOI:10.1038/jid.2012.388]
96 Sutton L,Guénel P,Tanguy ML,Rio B,Dhedin N,Casassus P,Lortholary O.Acute myeloid leukaemia in human immunodeficiency virus-infected adults:epidemiology,treatment feasibility and outcome.Br J Haematol 2001;112:900-908[PMID:11298584]
97 Aboulafia DM,Meneses M,Ginsberg S,Siegel MS,Howard WW,Dezube BJ.Acute myeloid leukemia in patients infected with HIV-1 .AIDS 2002;16:865-876[PMID:11919488]
98 Evans MW,Sung AD,Gojo I,Tidwell M,Greer J,Levis M,Karp J,Baer MR.Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.Leuk Lymphoma 2012;53:660 -664[PMID:21942284 DOI:10.3109/10428194.2011.624228]
99 Marcus JL,Chao CR,Leyden WA,Xu L,Klein DB,Horberg MA,Towner WJ,Quesenberry CP,Abrams DI,Van Den Eeden SK,Silverberg MJ.Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.J Acquir Immune Defic Syndr 2014;66:495-502[PMID:24820107DOI:10.1097/QAI.0000000000000202]
100 Silverberg MJ,Chao C,Leyden WA,Xu L,Horberg MA,Klein D,Towner WJ,Dubrow R,Quesenberry CP,Neugebauer RS,Abrams DI.HIV infection,immunodeficiency,viral replication,and the risk of cancer.Cancer Epidemiol Biomarkers Prev 2011;20:2551-2559[PMID:22109347 DOI:10.1158/1055-9965.EPI-11-0777]
101 Goedert JJ,Schairer C,Mc Neel TS,Hessol NA,Rabkin CS,Engels EA.Risk of breast,ovary,and uterine corpus cancers among 85 ,268 women with AIDS.Br J Cancer 2006;95:642-648[PMID:16868538 DOI:10.1038/sj.bjc.6603282]
2 Goedert JJ,CotéTR,Virgo P,Scoppa SM,Kingma DW,Gail MH,Jaffe ES,Biggar RJ.Spectrum of AIDS-associated malignant disorders.Lancet 1998;351:1833-1839[PMID:9652666]
3 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR Recomm Rep 1992;41:1-19[PMID:1361652]
4 Palella FJ,Baker RK,Moorman AC,Chmiel JS,Wood KC,Brooks JT,Holmberg SD.Mortality in the highly active antiretroviral therapy era:changing causes of death and disease in the HIV outpatient study.J Acquir Immune Defic Syndr 2006;43:27-34[PMID:16878047 DOI:10.1097/01.qai.0000233310.90484.16]
5 Mocroft A,Ledergerber B,Katlama C,Kirk O,Reiss P,d’Arminio Monforte A,Knysz B,Dietrich M,Phillips AN,Lundgren JD.Decline in the AIDS and death rates in the Euro SIDA study:an observational study.Lancet 2003;362:22-29[PMID:12853195DOI:10.1016/S0140-6736(03)13802-0]
6 Spano JP,Costagliola D,Katlama C,Mounier N,Oksenhendler E,Khayat D.AIDS-related malignancies:state of the art and therapeutic challenges.J Clin Oncol 2008;26:4834-4842[PMID:18591544 DOI:10.1200/JCO.2008.16.8252]
7 Grabar S,Abraham B,Mahamat A,Del Giudice P,Rosenthal E,Costagliola D.Differential impact of combination antiretroviral therapy in preventing Kaposi’s sarcoma with and without visceral involvement.J Clin Oncol 2006;24:3408-3414[PMID:16849755DOI:10.1200/JCO.2005.05.4072]
8 Hoffmann C,Wolf E,Fatkenheuer G,Buhk T,Stoehr A,Plettenberg A,Stellbrink HJ,Jaeger H,Siebert U,Horst HA.Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.AIDS 2003;17:1521-1529[PMID:12824790 DOI:10.1097/00002030-200307040-00013]
9 Bourboulia D,Aldam D,Lagos D,Allen E,Williams I,Cornforth D,Copas A,Boshoff C.Short-and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.AIDS 2004;18:485-493[PMID:15090801]
10 Besson C,Goubar A,Gabarre J,Rozenbaum W,Pialoux G,Chatelet FP,Katlama C,Charlotte F,Dupont B,Brousse N,Huerre M,Mikol J,Camparo P,Mokhtari K,Tulliez M,Salmon-Céron D,BouéF,Costagliola D,Rapha?l M.Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.Blood 2001;98:2339-2344[PMID:11588028 DOI:10.1182/blood.V98.8.2339]
11 Diamond C,Taylor TH,Aboumrad T,Anton-Culver H.Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy:incidence,presentation,treatment,and survival.Cancer 2006;106:128 -135[PMID:16329140 DOI:10.1002/cncr.21562]
12 Grogg KL,Miller RF,Dogan A.HIV infection and lymphoma.J Clin Pathol 2007;60:1365-1372[PMID:18042692 DOI:10.1136/jcp.2007.051953]
13 Engels EA,Pfeiffer RM,Goedert JJ,Virgo P,McN eel TS,Scoppa SM,Biggar RJ.Trends in cancer risk among people with AIDS in the United States 1980-2002.AIDS 2006;20:1645-1654[PMID:16868446 DOI:10.1097/01.aids.0000238411.75324.59]
14 Cobucci RN,Lima PH,de Souza PC,Costa VV,Cornetta Mda C,Fernandes JV,Goncalves AK.Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS:a systematic review.J Infect Public Health 2015;8:1-10[PMID:25294086 DOI:10.1016/j.jiph.2014.08.003]
15 Smith CJ,Ryom L,Weber R,Morlat P,Pradier C,Reiss P,Kowalska JD,de Wit S,Law M,el Sadr W,Kirk O,Friis-Moller N,Monforte Ad,Phillips AN,Sabin CA,Lundgren JD.Trends in underlying causes of death in people with HIV from 1999 to 2011(D:A:D):a multicohort collaboration.Lancet 2014;384:241-248[PMID:25042234 DOI:10.1016/S0140-6736(14)60604-8]
16 Grulich AE,Li Y,McD onald A,Correll PK,Law MG,Kaldor JM.Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis.AIDS 2002;16:1155-1161[PMID:12004274 DOI:10.1097/00002030-200205240-00009]
17 Newnham A,Harris J,Evans HS,Evans BG,Moller H.The risk of cancer in HIV-infected people in southeast England:a cohort study.Br J Cancer 2005;92:194-200[PMID:15583689 DOI:10 .1038/sj.bjc.6602273]
18 Bonnet F,Lewden C,May T,Heripret L,Jougla E,Bevilacqua S,Costagliola D,Salmon D,Chêne G,Morlat P.Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.Cancer 2004;101:317 -324[PMID:15241829 DOI:10.1002/cncr.2035]
19 Silverberg MJ,Chao C,Leyden WA,Xu L,Tang B,Horberg MA,Klein D,Quesenberry CP,Towner WJ,Abrams DI.HIV infection and the risk of cancers with and without a known infectious cause.AIDS 2009;23:2337-2345[PMID:19741479 DOI:10.1097/QAD.0b013e3283319184]
20 Dauby N,De Wit S,Delforge M,Necsoi VC,Clumeck N.Characteristics of non-AIDS-defining malignancies in the HAART era:a clinico-epidemiological study.J Int AIDS Soc 2011;14:16[PMID:21443771 DOI:10.1186/1758-2652-14-16]
21 Patel P,Hanson DL,Sullivan PS,Novak RM,Moorman AC,Tong TC,Holmberg SD,Brooks JT.Incidence of types of cancer among HIV-infected persons compared with the general population in the United States,1992-2003.Ann Intern Med 2008;148:728-736[PMID:18490686 DOI:10.7326/0003-4819-148-10-200805200-00005]
22 Calabresi A,Ferraresi A,Festa A,Scarcella C,Donato F,Vassallo F,Limina R,Castelli F,Quiros-Roldan E.Incidence of AIDSdefining cancers and virus-related and non-virus-related non-AIDSdefining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy,1999-2009.HIV Med 2013;14:481-490[PMID:23560682 DOI:10 .1111/hiv.12034]
23 Engels EA,Brock MV,Chen J,Hooker CM,Gillison M,Moore RD.Elevated incidence of lung cancer among HIV-infected individuals.J Clin Oncol 2006;24:1383-1388[PMID:16549832DOI:10.1200/JCO.2005.03.4413]
24 Simard EP,Engels EA.Cancer as a cause of death among people with AIDS in the United States.Clin Infect Dis 2010;51:957-962[PMID:20825305 DOI:10.1086/656416]
25 Grulich AE,van Leeuwen MT,Falster MO,Vajdic CM.Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients:a meta-analysis.Lancet 2007;370:59-67[PMID:17617273 DOI:10.1016/S0140-6736(07)61050-2]
26 Shiels MS,Cole SR,Kirk GD,Poole C.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.J Acquir Immune Defic Syndr 2009;52:611-622[PMID:19770804DOI:10.1097/QAI.0b013e3181b327ca]
27 Mani D,Haigentz M,Aboulafia DM.Lung cancer in HIV Infection.Clin Lung Cancer 2012;13:6-13[PMID:21802373DOI:10.1016/j.cllc.2011.05.005]
28 Burkhalter JE,Springer CM,Chhabra R,Ostroff JS,Rapkin BD.Tobacco use and readiness to quit smoking in low-income HIV-infected persons.Nicotine Tob Res 2005;7:511-522[PMID:16085522 DOI:10.1080/14622200500186064]
29 Centers for Disease Control and Prevention(CDC).Vital signs:current cigarette smoking among adults aged>or=18 years---United States,2009.MMWR Morb Mortal Wkly Rep 2010;59:1135-1140[PMID:20829747]
30 Flanders WD,Lally CA,Zhu BP,Henley SJ,Thun MJ.Lung cancer mortality in relation to age,duration of smoking,and daily cigarette consumption:results from Cancer Prevention Study II.Cancer Res 2003;63:6556-6562[PMID:14559851]
31 Shcherba M,Shuter J,Haigentz M.Current questions in HIVassociated lung cancer.Curr Opin Oncol 2013;25:511-517[PMID:23942294 DOI:10.1097/CCO.0b013e328363dfdb]
32 Sigel K,Wisnivesky J,Gordon K,Dubrow R,Justice A,Brown ST,Goulet J,Butt AA,Crystal S,Rimland D,Rodriguez-Barradas M,Gibert C,Park LS,Crothers K.HIV as an independent risk factor for incident lung cancer.AIDS 2012;26:1017-1025[PMID:22382152 DOI:10.1097/QAD.0b013e328352d1ad]
33 Chaturvedi AK,Pfeiffer RM,Chang L,Goedert JJ,Biggar RJ,Engels EA.Elevated risk of lung cancer among people with AIDS.AIDS 2007;21:207-213[PMID:17197812 DOI:10.1097/QAD.0b013e3280118fca]
34 Rengan R,Mitra N,Liao K,Armstrong K,Vachani A.Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy:a population-based study.Lancet Oncol 2012;13:1203-1209[PMID:23164952 DOI:10 .1016/S1470-2045(12)70466-7]
35 D’Jaen GA,Pantanowitz L,Bower M,Buskin S,Neil N,Greco EM,Cooley TP,Henry D,Stem J,Dezube BJ,Stebbing J,Aboulafia DM.Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy:a multiinstitutional collaboration.Clin Lung Cancer 2010;11:396-404[PMID:21062730 DOI:10.3816/CLC.2010.n.051]
36 Hakimian R,Fang H,Thomas L,Edelman MJ.Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.J Thorac Oncol 2007;2:268-272[PMID:17409796 DOI:10 .1097/01.JTO.0000263707.31202.d7]
37 Powles T,Nelson M,Bower M.HIV-related lung cancer--a growing concern?Int J STD AIDS 2003;14:647-651[PMID:14596765 DOI:10.1258/095646203322387875]
38 Makinson A,Tenon JC,Eymard-Duvernay S,Pujol JL,Allavena C,Cuzin L,Poizot-Martin I,de la Tribonnière X,CabiéA,Pugliese P,Reynes J,Le Moing V.Human immunodeficiency virus infection and non-small cell lung cancer:survival and toxicity of antineoplastic chemotherapy in a cohort study.J Thorac Oncol 2011;6:1022-1029[PMID:21512403 DOI:10.1097/JTO.0b013e318217b6e0]
39 Persad GC,Little RF,Grady C.Including persons with HIV infection in cancer clinical trials.J Clin Oncol 2008;26:1027-1032[PMID:18309938 DOI:10.1200/JCO.2007.14.5532]
40 Bearz A,Vaccher E,Martellotta F,Spina M,Talamini R,Lleshi A,Cacopardo B,Nunnari G,Berretta M,Tirelli U.Lung cancer in HIV positive patients:the GICAT experience.Eur Rev Med Pharmacol Sci 2014;18:500-508[PMID:24610616]
41 Bedimo R,Chen RY,Accortt NA,Raper JL,Linn C,Allison JJ,Dubay J,Saag MS,Hoesley CJ.Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients:1989-2002.Clin Infect Dis 2004;39:1380-1384[PMID:15494916DOI:10.1086/424883]
42 Berretta M,Cappellani A,Di Benedetto F,Lleshi A,Talamini R,Canzonieri V,Zanet E,Bearz A,Nasti G,Lacchin T,Berretta S,Fisichella R,Balestreri L,Torresin A,Izzi I,Ortolani P,Tirelli U.Clinical presentation and outcome of colorectal cancer in HIVpositive patients:a clinical case-control study.Onkologie 2009;32:319 -324[PMID:19521118 DOI:10.1159/000215719]
43 Berretta M,Zanet E,Basile F,Ridolfo AL,Di Benedetto F,Bearz A,Berretta S,Nasti G,Tirelli U.HIV-positive patients with liver metastases from colorectal cancer deserve the same therapeutic approach as the general population.Onkologie 2010;33:203-204[PMID:20389148 DOI:10.1159/000292126]
44 Bini EJ,Green B,Poles MA.Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects.Gut 2009;58:1129-1134[PMID:19293177 DOI:10 .1136/gut.2008.165985]
45 Franceschi S,Lise M,Clifford GM,Rickenbach M,Levi F,Maspoli M,Bouchardy C,Dehler S,Jundt G,Ess S,Bordoni A,Konzelmann I,Frick H,Dal Maso L,Elzi L,Furrer H,Calmy A,Cavassini M,Ledergerber B,Keiser O.Changing patterns of cancer incidence in the early-and late-HAART periods:the Swiss HIV Cohort Study.Br J Cancer 2010;103:416-422[PMID:20588274DOI:10.1038/sj.bjc.6605756]
46 Gotti D,Raffetti E,Albini L,Sighinolfi L,Maggiolo F,Di Filippo E,Ladisa N,Angarano G,Lapadula G,Pan A,Esposti AD,Fabbiani M,FocàE,Scalzini A,Donato F,Quiros-Roldan E.Survival in HIVinfected patients after a cancer diagnosis in the cA RT Era:results of an italian multicenter study.PLoS One 2014;9:e94768[PMID:24760049 DOI:10.1371/journal.pone.0094768]
47 Guiguet M,BouéF,Cadranel J,Lang JM,Rosenthal E,Costagliola D.Effect of immunodeficiency,HIV viral load,and antiretroviral therapy on the risk of individual malignancies(FHDH-ANRS CO4):a prospective cohort study.Lancet Oncol 2009;10:1152-1159[PMID:19818686 DOI:10.1016/S1470-2045(09)70282-7]
48 Babu CK,Suwansrinon K,Bren GD,Badley AD,Rizza SA.HIV induces TRAIL sensitivity in hepatocytes.PLoS One 2009;4:e4623[PMID:19247452 DOI:10.1371/journal.pone.0004623]
49 Sulkowski MS,Thomas DL,Chaisson RE,Moore RD.Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.JAMA 2000;283:74-80[PMID:10632283 DOI:10.1001/jama.283.1.74]
50 Clifford GM,Rickenbach M,Polesel J,Dal Maso L,Steffen I,Ledergerber B,Rauch A,Probst-Hensch NM,Bouchardy C,Levi F,Franceschi S.Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.AIDS 2008;22:2135-2141[PMID:18832877 DOI:10.1097/QAD.0b013e32831103ad]
51 Berretta M,Garlassi E,Cacopardo B,Cappellani A,Guaraldi G,Cocchi S,De Paoli P,Lleshi A,Izzi I,Torresin A,Di Gangi P,Pietrangelo A,Ferrari M,Bearz A,Berretta S,Nasti G,Di Benedetto F,Balestreri L,Tirelli U,Ventura P.Hepatocellular carcinoma in HIV-infected patients:check early,treat hard.Oncologist 2011;16:1258-1269[PMID:21868692 DOI:10.1634/theoncologist.2010-0400]
52 Bower M,Palfreeman A,Alfa-Wali M,Bunker C,Burns F,Churchill D,Collins S,Cwynarski K,Edwards S,Fields P,Fife K,Gallop-Evans E,Kassam S,Kulasegaram R,Lacey C,Marcus R,Montoto S,Nelson M,Newsom-Davis T,Orkin C,Shaw K,Tenant-Flowers M,Webb A,Westwell S,Williams M.British HIV Association guidelines for HIV-associated malignancies 2014.HIV Med 2014;15 Suppl 2:1-92[PMID:24528810 DOI:10.1111/hiv.12136]
53 Vibert E,Duclos-Vallée JC,Ghigna MR,Hoti E,Salloum C,Guettier C,Castaing D,Samuel D,Adam R.Liver transplantation for hepatocellular carcinoma:the impact of human immunodeficiency virus infection.Hepatology 2011;53:475-482[PMID:21274869DOI:10.1002/hep.24062]
54 Di Benedetto F,Tarantino G,Ercolani G,Baccarani U,Montalti R,De Ruvo N,Berretta M,Adani GL,Zanello M,Tavio M,Cautero N,Tirelli U,Pinna AD,Gerunda GE,Guaraldi G.Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients.Oncologist 2013;18:592-599[PMID:23666950 DOI:10.1634/theoncologist.2012-0255]
55 Rockstroh JK,Bhagani S,Benhamou Y,Bruno R,Mauss S,Peters L,Puoti M,Soriano V,Tural C.European AIDS Clinical Society(EACS)guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.HIV Med 2008;9:82-88[PMID:18257771 DOI:10.1111/j.1468-1293.2007.00535.x]
56 Clausen LN,Lundbo LF,Benfield T.Hepatitis C virus infection in the human immunodeficiency virus infected patient.World J Gastroenterol 2014;20:12132-12143[PMID:25232248 DOI:10 .3748/wjg.v20.i34.12132]
57 Biggar RJ,Jaffe ES,Goedert JJ,Chaturvedi A,Pfeiffer R,Engels EA.Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.Blood 2006;108:3786-3791[PMID:16917006 DOI:10 .1182/blood-2006-05-024109]
58 Engels EA,Biggar RJ,Hall HI,Cross H,Crutchfield A,Finch JL,Grigg R,Hylton T,Pawlish KS,Mc Neel TS,Goedert JJ.Cancer risk in people infected with human immunodeficiency virus in the United States.Int J Cancer 2008;123:187-194[PMID:18435450DOI:10.1002/ijc.23487]
59 Said JW.Immunodeficiency-related Hodgkin lymphoma and its mimics.Adv Anat Pathol 2007;14:189-194[PMID:17452815DOI:10.1097/PAP.0b013e31805048fc]
60 Rezk SA,Weiss LM.Epstein-Barr virus-associated lymphoproliferative disorders.Hum Pathol 2007;38:1293-1304[PMID:17707260 DOI:10.1016/j.humpath.2007.05.020]
61 Spina M,Carbone A,Gloghini A,Serraino D,Berretta M,Tirelli U.Hodgkin’s Disease in Patients with HIV Infection.Adv Hematol 2011;2011:pii:402682[PMID:20936156 DOI:10.1155/2011/402682]
62 Berenguer J,Miralles P,Ribera JM,Rubio R,Valencia E,Mahillo B,Pintado V,Palacios R,Montes ML,Téllez MJ,La Cruz J,TorreCisneros J,Rodríguez-Arrondo F,Sepúlveda MA,Gutiérrez F,Peralta G,Boix V.Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.J Acquir Immune Defic Syndr 2008;47:422 -428[PMID:18434957 DOI:10.1097/QAI.0b013e31815e722b]
63 Levine AM,Li P,Cheung T,Tulpule A,Von Roenn J,Nathwani BN,Ratner L.Chemotherapy consisting of doxorubicin,bleomycin,vinblastine,and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin’s disease:a prospective,multi-institutional AIDS clinical trials group study(ACTG 149).J Acquir Immune Defic Syndr 2000;24:444-450[PMID:11035615 DOI:10.1097/00126334-200008150-00009]
64 Hartmann P,Rehwald U,Salzberger B,Franzen C,Sieber M,W?hrmann A,Diehl V.BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection.Ann Oncol 2003;14:1562-1569[PMID:14504059 DOI:10.1093/annonc/mdg408]
65 Spina M,Gabarre J,Rossi G,Fasan M,Schiantarelli C,Nigra E,Mena M,Antinori A,Ammassari A,Talamini R,Vaccher E,di Gennaro G,Tirelli U.Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.Blood 2002;100:1984-1988[PMID:12200356 DOI:10.1182/blood-2002-03-0989]
66 Spina M,Rossi G,Antinori A.VEBEP regimen and highly active antiretroviral therapy(HAART)in patients(pts)with HD and HIV infection(HD-HIV)-ASCO.J Clin Oncol 2007;25:8083
67 Krishnan A,Molina A,Zaia J,Smith D,Vasquez D,Kogut N,Falk PM,Rosenthal J,Alvarnas J,Forman SJ.Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.Blood 2005;105:874-878[PMID:15388574 DOI:10 .1182/blood-2004-04-1532]
68 Re A,Michieli M,Casari S,Allione B,Cattaneo C,Rupolo M,Spina M,Manuele R,Vaccher E,Mazzucato M,Abbruzzese L,Ferremi P,Carosi G,Tirelli U,Rossi G.High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma:long-term results of the Italian Cooperative Group on AIDS and Tumors(GICAT)study with analysis of prognostic factors.Blood 2009;114:1306-1313[PMID:19451551 DOI:10.1182/blood-2009-02-202762]
69 Zanet E,Berretta M,Martellotta F,Cacopardo B,Fisichella R,Tavio M,Berretta S,Tirelli U.Anal cancer:Focus on HIV-positive patients in the HAART-era.Curr HIV Res 2011;9:70-81[PMID:21410431 DOI:10.2174/157016211795569087]
70 D’Souza G,Wiley DJ,Li X,Chmiel JS,Margolick JB,Cranston RD,Jacobson LP.Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.J Acquir Immune Defic Syndr 2008;48:491-499[PMID:18614927 DOI:10.1097/QAI.0b013e31817aebfe]
71 Piketty C,Selinger-Leneman H,Bouvier AM,Belot A,MaryKrause M,Duvivier C,Bonmarchand M,Abramowitz L,Costagliola D,Grabar S.Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment:results from the french hospital database on HIV.J Clin Oncol 2012;30:4360-4366[PMID:23091098 DOI:10.1200/JCO.2012.44.5486]
72 Kreuter A,Potthoff A,Brockmeyer NH,Gambichler T,Swoboda J,Stücker M,Schmitt M,Pfister H,Wieland U.Anal carcinoma in human immunodeficiency virus-positive men:results of a prospective study from Germany.Br J Dermatol 2010;162:1269-1277[PMID:20184584 DOI:10.1111/j.1365-2133.2010.09712.x]
73 Watson AJ,Smith BB,Whitehead MR,Sykes PH,Frizelle FA.Malignant progression of anal intra-epithelial neoplasia.ANZ J Surg 2006;76:715-717[PMID:16916390 DOI:10.1111/j.1445-2197.2006.03837.x]
74 Frisch M,Biggar RJ,Goedert JJ.Human papillomavirusassociated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.J Natl Cancer Inst 2000;92:1500-1510[PMID:10995805 DOI:10.1093/jnci/92.18.1500]
75 Machalek DA,Poynten M,Jin F,Fairley CK,Farnsworth A,Garland SM,Hillman RJ,Petoumenos K,Roberts J,Tabrizi SN,Templeton DJ,Grulich AE.Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men:a systematic review and meta-analysis.Lancet Oncol 2012;13:487 -500[PMID:22445259 DOI:10.1016/S1470-2045(12)70080-3]
76 Cleator S,Fife K,Nelson M,Gazzard B,Phillips R,Bower M.Treatment of HIV-associated invasive anal cancer with combined chemoradiation.Eur J Cancer 2000;36:754-758[PMID:10762748]
77 Dandapani SV,Eaton M,Thomas CR,Pagnini PG.HIV-positive anal cancer:an update for the clinician.J Gastrointest Oncol 2010;1:34 -44[PMID:22811803 DOI:10.3978/j.issn.2078-6891.2010.005]
78 Lam JM,Hoch JS,Tinmouth J,Sano M,Raboud J,Salit IE.Costeffectiveness of screening for anal precancers in HIV-positive men.AIDS 2011;25:635-642[PMID:21139488 DOI:10.1097/QAD.0b013e3283434594]
79 Kreimer AR,González P,Katki HA,Porras C,Schiffman M,Rodriguez AC,Solomon D,Jiménez S,Schiller JT,Lowy DR,van Doorn LJ,Struijk L,Quint W,Chen S,Wacholder S,Hildesheim A,Herrero R.Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women:a nested analysis within the Costa Rica Vaccine Trial.Lancet Oncol 2011;12:862-870[PMID:21865087 DOI:10.1016/S1470-2045(11)70213-3]
80 Mehrany K,Weenig RH,Lee KK,Pittelkow MR,Otley CC.Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.J Am Acad Dermatol 2005;53:1067-1071[PMID:16310071 DOI:10 .1016/j.jaad.2005.08.055]
81 Euvrard S,Kanitakis J,Claudy A.Skin cancers after organ transplantation.N Engl J Med 2003;348:1681-1691[PMID:12711744 DOI:10.1056/NEJMra022137]
82 Crum-Cianflone N,Hullsiek KH,Satter E,Marconi V,Weintrob A,Ganesan A,Barthel RV,Fraser S,Agan BK.Cutaneous malignancies among HIV-infected persons.Arch Intern Med 2009;169:1130-1138[PMID:19546414 DOI:10.1001/archinternmed.2009.104]
83 Clifford GM,Polesel J,Rickenbach M,Dal Maso L,Keiser O,Kofler A,Rapiti E,Levi F,Jundt G,Fisch T,Bordoni A,De Weck D,Franceschi S.Cancer risk in the Swiss HIV Cohort Study:associations with immunodeficiency,smoking,and highly active antiretroviral therapy.J Natl Cancer Inst 2005;97:425-432[PMID:15770006 DOI:10.1093/jnci/dji072]
84 Olsen CM,Knight LL,Green AC.Risk of melanoma in people with HIV/AIDS in the pre-and post-HAART eras:a systematic review and meta-analysis of cohort studies.PLo S One 2014;9:e95096[PMID:24740329 DOI:10.1371/journal.pone.0095096]
85 Maurer TA,Christian KV,Kerschmann RL,Berzin B,Palefsky JM,Payne D,Tyring SK,Berger TG.Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients.A study of epidemiologic risk factors,human papillomavirus,and p53expression.Arch Dermatol 1997;133:577-583[PMID:9158410DOI:10.1001/archderm.1997.03890410031004]
86 Lobo DV,Chu P,Grekin RC,Berger TG.Nonmelanoma skin cancers and infection with the human immunodeficiency virus.Arch Dermatol 1992;128:623-627[PMID:1575523 DOI:10.1001/archderm.1992.01680150053003]
87 Hausauer AK,Maurer T,Leslie KS,Parvataneni R,Stuart SE,Chren MM.Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus.JAMA Dermatol 2013;149:239-241[PMID:23426494 DOI:10.1001/2013.jamadermatol.245]
88 Izikson L,Nornhold E,Iyer JG,Nghiem P,Zeitouni NC.Merkel cell carcinoma associated with HIV:review of 14patients.AIDS 2011;25:119-121[PMID:21119325 DOI:10.1097/QAD.0b013e328340a19c]
89 Engels EA,Frisch M,Goedert JJ,Biggar RJ,Miller RW.Merkel cell carcinoma and HIV infection.Lancet 2002;359:497-498[PMID:11853800 DOI:10.1016/S0140-6736(02)07668-7]
90 Feng H,Shuda M,Chang Y,Moore PS.Clonal integration of a polyomavirus in human Merkel cell carcinoma.Science 2008;319:1096-1100[PMID:18202256 DOI:10.1126/science.1152586]
91 Foulongne V,Kluger N,Dereure O,Brieu N,Guillot B,Segondy M.Merkel cell polyomavirus and Merkel cell carcinoma,France.Emerg Infect Dis 2008;14:1491-1493[PMID:18760031DOI:10.3201/eid1409.080651]
92 Becker JC,Houben R,Ugurel S,Trefzer U,Pfohler C,Schrama D.MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.J Invest Dermatol 2009;129:248-250[PMID:18633441 DOI:10.1038/jid.2008.198]
93 Brugnaro P,Morelli E,Fiscon M,Ebo F,Rosini G,Belussi F,Eseme F,Mione CA,Donisi PM,Raise E.Sustained remission of a primary nodal Merkel cell carcinoma in an HIV-positive patient.Onkologie 2011;34:190-192[PMID:21447977 DOI:10 .1159/000327000]
94 Busse PM,Clark JR,Muse VV,Liu V.Case records of the Massachusetts General Hospital.Case 19-2008.A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma.N Engl J Med 2008;358:2717-2723[PMID:18565865 DOI:10.1056/NEJMcpc0803063]
95 Paulson KG,Iyer JG,Blom A,Warton EM,Sokil M,Yelistratova L,Schuman L,Nagase K,Bhatia S,Asgari MM,Nghiem P.Systemic immune suppression predicts diminished Merkel cell carcinomaspecific survival independent of stage.J Invest Dermatol 2013;133:642 -646[PMID:23190897 DOI:10.1038/jid.2012.388]
96 Sutton L,Guénel P,Tanguy ML,Rio B,Dhedin N,Casassus P,Lortholary O.Acute myeloid leukaemia in human immunodeficiency virus-infected adults:epidemiology,treatment feasibility and outcome.Br J Haematol 2001;112:900-908[PMID:11298584]
97 Aboulafia DM,Meneses M,Ginsberg S,Siegel MS,Howard WW,Dezube BJ.Acute myeloid leukemia in patients infected with HIV-1 .AIDS 2002;16:865-876[PMID:11919488]
98 Evans MW,Sung AD,Gojo I,Tidwell M,Greer J,Levis M,Karp J,Baer MR.Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.Leuk Lymphoma 2012;53:660 -664[PMID:21942284 DOI:10.3109/10428194.2011.624228]
99 Marcus JL,Chao CR,Leyden WA,Xu L,Klein DB,Horberg MA,Towner WJ,Quesenberry CP,Abrams DI,Van Den Eeden SK,Silverberg MJ.Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.J Acquir Immune Defic Syndr 2014;66:495-502[PMID:24820107DOI:10.1097/QAI.0000000000000202]
100 Silverberg MJ,Chao C,Leyden WA,Xu L,Horberg MA,Klein D,Towner WJ,Dubrow R,Quesenberry CP,Neugebauer RS,Abrams DI.HIV infection,immunodeficiency,viral replication,and the risk of cancer.Cancer Epidemiol Biomarkers Prev 2011;20:2551-2559[PMID:22109347 DOI:10.1158/1055-9965.EPI-11-0777]
101 Goedert JJ,Schairer C,Mc Neel TS,Hessol NA,Rabkin CS,Engels EA.Risk of breast,ovary,and uterine corpus cancers among 85 ,268 women with AIDS.Br J Cancer 2006;95:642-648[PMID:16868538 DOI:10.1038/sj.bjc.6603282]